Cognitive-behavioral therapy for insomnia during benzodiazepine withdrawal in older individuals
- Conditions
- Chronic insomniaMental and Behavioural Disorders
- Registration Number
- ISRCTN10037794
- Lead Sponsor
- Institut Universitaire De Gériatrie De Montréal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 48
1. Meeting DSM-V diagnostic criteria for insomnia disorder:
1.1. sleep initiation difficulties (sleep latency > 30min after switching off the lights)
1.2. and/or sleep maintenance difficulties (waking up > 30min during the night)
1.3. negative diurnal repercussions
• for more than 3 months, at least 3 times per week
2. Aged 60 years or older
3. Ability to speak and understand French (as CBTi sessions are conducted in French)
4. Chronic BZD or BZRA use: more than 3 times per week, for more than 3 months
1. Cognitive deficits with MMSE score equal to or less than 23/30
2. Dementia
3. Parkinson's disease
4. Severe sensorimotor deficit (including severe visual or hearing impairment)
5. Epilepsy, anti-epileptic medication
6. Major depression
7. Psychotic disorder, anti-psychotic medication
8. Other psychotropic drugs prescribed for sleep
9. Recent history of alcoholism or drug abuse
10. Moderate to severe sleep apnea syndrome
11. Palliative care
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The following are assessed at the baseline, post-treatment/post-waiting period:<br>1. Questionnaire: Insomnia Severity Index (ISI)<br>2. Sleep efficiency from polysomnographic recordings and sleep diary<br>3. N3 sleep stage duration from polysomnographic recordings <br>4. Sleep spindle density from polysomnographic recordings
- Secondary Outcome Measures
Name Time Method